Experts discussed how NALIRIFOX compares with FOLFIRINOX and gemcitabine/nab-paclitaxel as frontline therapy for metastatic pancreatic cancer.
Navigating First-Line Treatment in Metastatic Pancreatic Adenocarcinoma
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Cancer Vaccine Meets Primary, Secondary End Points in Resected Melanoma
2
Who Are The Key Candidates to Receive Subcutaneous Amivantamab for HNSCC?
3
ccRCC PET Imaging Agent Earns FDA Breakthrough Therapy, Fast Track Statuses
4
Weighing Bispecific Antibodies Against CAR T Cells in Multiple Myeloma
5